Appvance, the leader in AI-driven software test automation, today announced the issuance of U.S. Patent No. 12,353,317 for ...

Hi readers! I hope that you are also fine and would like to know something new. The brightest apps start with a simple ...

Progress towards The Lancet Commission on Global Surgery's 2030 targets has been too slow and too patchy, particularly in low-income and middle-income countries. The unmet need for surgery has ...

Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.